首页 > 市场调查报告书 > 医疗设备

体外诊断

药物滥用检测市场规模、份额和成长分析（按产品类型、检体类型、应用、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900441

药物滥用检测市场规模、份额和成长分析（按产品类型、检体类型、应用、最终用户和地区划分）－2026-2033年产业预测

Drug of Abuse Testing Market Size, Share, and Growth Analysis, By Product Type (Analyzers, Rapid Testing Devices), By Sample Type (Saliva, Breath), By Application, By End-user, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月18日 | 出版商:

SkyQuest | 英文 198 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球药物滥用检测市场规模预计在 2024 年达到 40.2 亿美元，从 2025 年的 42.5 亿美元增长到 2033 年的 66.8 亿美元，在预测期（2026-2033 年）内复合年增长率为 5.8%。

受药物滥用日益猖獗、行业监管日益严格以及人们对药物检测在医疗保健和职场场所重要性认识不断提高的推动，全球药物滥用检测市场正经历强劲增长。政府为促进合规和意识提升而采取的倡议，显着推动了对打击药物滥用检测服务的需求。非法药物生产和贩运的增加进一步凸显了检测服务的必要性。然而，诸如检测某些物质微量成分的局限性以及不断变化的药物合法化法律可能带来的影响等挑战，都对市场动态构成风险。儘管存在这些障碍，检测技术的创新以及药物筛检与医疗保健服务的融合，为市场扩张提供了巨大的机会。

全球药物滥用检测市场驱动因素

新型毒品和非法毒品的生产、消费和分销的增加是推动药物滥用检测（DoA）需求成长的关键因素，从而促进了市场发展。吸毒者的高发生率凸显了对有效药物滥用检测解决方案的迫切需求，推动了该产业的发展。此外，政府旨在意识提升并促进组织内部合规性的倡议预计也将支持市场扩张。同时，对具有更高特异性和灵敏度的合成药物检测产品的需求不断增长，进一步巩固了药物滥用检测市场的成长。

限制全球药物滥用检测市场的因素

全球药物滥用检测市场面临许多可能阻碍其成长潜力的重大障碍。其中一个主要问题是现有检测产品无法有效检测某些药物的微量成分。此外，旨在将娱乐性药物和非法药物合法化的立法不断变化，也为市场扩张带来了额外的挑战。对该市场进行全面评估，可以深入了解近期发展、法律规范、贸易趋势、价值链效率、竞争格局、新兴机会和技术进步等方面的关键资讯。对于希望在不断变化的药物检测领域中把握未来成长机会的相关人员而言，了解这些因素至关重要。

全球药物滥用检测市场趋势

全球药物滥用检测市场正显着转向更广泛地采用就地检验解决方案。这一趋势凸显了对快速且方便的药物检测方法日益增长的需求，这些方法可在各种非实验室环境中进行，例如诊所、职场和偏远地区。即时检测结果的便利性满足了人们对及时介入日益增长的需求，尤其是在紧急情况和职业健康领域。随着相关人员优先考虑效率和柔软性，检测技术的创新正在进一步加速这一趋势，并塑造药物滥用检测解决方案的未来。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Abbott Laboratories（US）
Thermo Fisher Scientific Inc.（US）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche Ltd（Switzerland）
Quest Diagnostics Incorporated（US）
Bio-Rad Laboratories, Inc.（US）
Dragerwerk AG & Co. KGaA（Germany）
Biomerieux SA（France）
Shimadzu Corporation（Japan）
Randox Laboratories Ltd.（United Kingdom）
Psychemedics Corporation（US）
Sonic Healthcare（Australia）
Merck KGaA（Germany）
LabCorp（US）
MP Biomedicals LLC（US）
Omega Laboratories, Inc.（US）
Express Diagnostics International Inc.（US）
Sciteck, Inc.（US）

结论与建议

简介目录

Product Code: SQMIG35H2250

Global Drug of Abuse Testing Market size was valued at USD 4.02 Billion in 2024 and is poised to grow from USD 4.25 Billion in 2025 to USD 6.68 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global drug of abuse testing market is witnessing robust growth driven by the rising incidence of substance abuse, strict industry regulations, and heightened awareness of the significance of drug testing in healthcare and workplace environments. A substantial demand for drug testing services is emerging to combat substance abuse, alongside government initiatives promoting compliance and awareness. Increased production and trade of illicit drugs further underscore the necessity for testing services. However, challenges such as limitations in detecting trace amounts of certain substances and the potential impact of evolving drug legalization laws pose risks to market dynamics. Despite these obstacles, innovations in testing technologies and the integration of drug screening with healthcare services present significant opportunities for market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug of Abuse Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug of Abuse Testing Market Segments Analysis

Global Drug of Abuse Testing Market is segmented by Product Type, Sample Type, Testing Type, End-user and region. Based on Product Type, the market is segmented into Analyzers, Rapid Testing Devices and Consumables. Based on Sample Type, the market is segmented into Saliva, Breath, Urine, Blood and Hair & Sweat. Based on Application, the market is segmented into Medical Screening, Monitoring Pain Management, Forensic & Legal Information, Employment Drug Testing, Sports & Athletics Testing. Based on End-user, the market is segmented into Hospitals, Diagnostics Laboratories, On-the-spot Testing and Forensic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug of Abuse Testing Market

The increasing production, consumption, and distribution of both new and illicit drugs are significant factors driving the demand for Drug of Abuse (DoA) testing, consequently stimulating market growth. The high prevalence of drug users highlights the urgent need for effective DoA testing solutions, propelling the industry forward. Furthermore, government initiatives designed to raise awareness about drug abuse and promote compliance within organizations are expected to support market expansion. Additionally, there is a rising demand for testing products that provide enhanced specificity and sensitivity in detecting designer drugs, which further strengthens the growth of the Drug of Abuse testing market.

Restraints in the Global Drug of Abuse Testing Market

The Global Drug of Abuse Testing market is encountering significant obstacles that may hinder its growth potential. One primary concern is the inadequacy of existing testing products, which struggle to effectively detect minute quantities of certain drugs. Furthermore, the ongoing shifts in legislation aimed at legalizing recreational and illicit substances present additional challenges for market expansion. Comprehensive assessments of the market reveal crucial insights into recent advancements, regulatory frameworks, trade dynamics, value chain efficiency, competitive landscape, emerging opportunities, and technological progressions. Addressing these factors is essential for stakeholders looking to navigate the evolving environment of drug testing and capitalize on future growth prospects.

Market Trends of the Global Drug of Abuse Testing Market

The Global Drug of Abuse Testing market is witnessing a pronounced shift towards the increasing adoption of point-of-care testing solutions. This trend highlights a growing demand for rapid and accessible drug testing methods that can be conducted in various non-laboratory environments, including clinics, workplaces, and remote locations. The convenience and immediacy of obtaining test results at the point of care cater to the rising need for timely interventions, particularly in emergency and occupational health contexts. As stakeholders prioritize efficiency and flexibility, innovations in testing technology are further propelling this movement, shaping the future landscape of drug abuse testing solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Studies

Global Drug of Abuse Testing Market Size by Product Type & CAGR (2026-2033)

Market Overview
Analyzers
- Immunoassays Analyzers
- Chromatographic Devices
- Breath Analyzers
Rapid Testing Devices
- Urine Testing Devices
- Oral Fluid Testing Devices
Consumables
- Fluid Collection Devices
- Others

Global Drug of Abuse Testing Market Size by Sample Type & CAGR (2026-2033)

Market Overview
Saliva
Breath
Urine
Blood
Hair & Sweat

Global Drug of Abuse Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Medical Screening
Monitoring Pain Management
Forensic & Legal Information
Employment Drug Testing
Sports & Athletics Testing

Global Drug of Abuse Testing Market Size by End-user & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostics Laboratories
On-the-spot Testing
Forensic Laboratories

Global Drug of Abuse Testing Market Size & CAGR (2026-2033)

North America (Product Type, Sample Type, Application, End-user)
- US
- Canada
Europe (Product Type, Sample Type, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Sample Type, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Sample Type, Application, End-user)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Sample Type, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LabCorp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MP Biomedicals LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Express Diagnostics International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments